Ginkgo Bioworks Holdings (DNA) Enterprise Value (2019 - 2026)

Ginkgo Bioworks Holdings has reported Enterprise Value for 8 years, with the latest figure at -$143.9 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 53.95% year-over-year to -$143.9 million; the trailing twelve-month figure through Mar 2026 stood at -$143.9 million (up 53.95% YoY), and the FY2025 full-year result was -$422.6 million, up 24.74% from the prior year.
• Enterprise Value for Q1 2026 stood at -$143.9 million, up from -$422.6 million in the prior quarter.
• The five-year high for Enterprise Value was -$111.1 million in Q3 2025, with the low at -$1.5 billion in Q1 2022.
• Historically, Enterprise Value has averaged -$803.9 million across 5 years, with a median of -$840.4 million in 2024.
• Annual changes were most pronounced in 2022 — Enterprise Value slumped 470.4% — and 2025, when it surged 81.98%.
• Ginkgo Bioworks Holdings' Enterprise Value stood at -$1.3 billion in 2022, then increased by 28.25% to -$944.1 million in 2023, then surged by 40.52% to -$561.6 million in 2024, then grew by 24.74% to -$422.6 million in 2025, then soared by 65.96% to -$143.9 million in 2026.
• The last three Enterprise Value figures came in at -$143.9 million (Q1 2026), -$422.6 million (Q4 2025), and -$111.1 million (Q3 2025), per Business Quant data.